AI assistant
Telecure Technologies Inc. — Board/Management Information 2022
Feb 5, 2022
47777_rns_2022-02-04_cc072a86-ce9f-48b7-84fe-a8a99821aff5.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [378 x 106] intentionally omitted <==
Telecure Technologies Inc. Announces Change to its Board of Directors
February 4, 2022
Vancouver, BC – Telecure Technologies Inc. (CSE: TELE) (FSE: 6MZ) (the “ Company ” or “ Telecure ”) a U.S. focused health IT company which develops technology to make healthcare more accessible and efficient, is pleased announce that Mr. Amandeep Parmar has been appointed to its Board of Directors.
The Company wishes to welcome Aman Parmar to its board of directors effective immediately. Mr. Parmar’s corporate experience includes over 15 years’ working with both public and private companies in the resources, health care, manufacturing, and real estate sectors. He has extensive experience in the capital markets and has been involved in corporate restructuring and financing for both public and private companies. He obtained a Chartered Accountant designation in 2012 and holds a Bachelor of Technology in Accounting from the British Columbia Institute of Technology.
Telecure also announces the departure of Mr. Eli Dusenbury from the Board of Directors. Mr. Dusenbury remains as Chief Financial Officer for Telecure. The Company wishes to thank Mr. Dusenbury for his ongoing dedicated support.
On Behalf of the Board of Directors
Josh Rosenberg Chairman of the Board of Directors
Contact
Phone: 604 398-3432 Email: [email protected]
About Telecure Technologies Inc.
Telecure is a U.S. focused health IT company that specializes in using technology to make healthcare more accessible and efficient. Telecure offers customized solutions for telemedicine needs. Through an acquisition strategy and unique customization capabilities, Telecure is focused on advancing its patient and user base. The Company provides a complete telemedicine solution via its platforms CallingDr[TM] and FindingDr[TM] .
Forward-Looking Statements
This news release may contain "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future of the Company’s business, its product offerings and plans for growth. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward- looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported.
The Canadian Securities Exchange (CSE) has not reviewed, approved or disapproved the contents of this press release.